Chong Kun Dang Holdings Corp. (KRX:001630)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Consolidation Adjustment			-31.58B	-50.47B	-68.33B	-42.22B		-42.12B
Medicine			846.81B	897.37B	928.41B	851.48B		508.25B
Medicine Growth			-5.63%	-3.34%	9.03%	-		16.60%
Other			64.55B	62.07B	65.89B	48.85B		64.99B
Other Growth			3.99%	-5.80%	34.88%	-		124.31%
Total			879.78B	908.96B	925.98B	858.12B		531.11B
Total Growth			-3.21%	-1.84%	7.91%	-		17.83%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
South Korea			724.60B	803.42B	824.01B	709.09B		377.75B
South Korea Growth			-9.81%	-2.50%	16.21%	-		37.95%
Asia			76.15B	89.27B	89.27B	109.28B		98.82B
Asia Growth			-14.69%	0%	-18.32%	-		-5.32%
Europe			56.28B	27.79B	27.79B	21.21B		37.75B
Europe Growth			102.51%	0%	31.05%	-		2.10%
Middle East			12.90B	2.49B	2.49B	13.35B		9.15B
Middle East Growth			417.98%	0%	-81.34%	-		-13.48%
Other			34.47B	26.58B	26.58B	47.40B		49.77B
Other Growth			29.67%	0%	-43.92%	-		27.22%
Consolidation Adjustment			-24.74B	-40.71B	-51.45B	-42.22B		-42.12B
Total			879.66B	908.84B	918.68B	858.12B		531.11B
Total Growth			-3.21%	-1.07%	7.06%	-		17.83%

Source: S&P Global Market Intelligence.